Welcome to Beers with Rich, I’m Rich, founder of Under the Radar Report. You’re all wondering, how’s #GetRichWithRich going?
Ansarada (ASX: $AND) up 30%
We got off to a flyer with Ansarada (AND) this week, which is 30% up since I mentioned it last week.
Two Shares I’ve bought this week
I’ve bought $500 worth of an ETF A200, as well as CSL Limited (ASX:CSL), which is now trading at over $286 a share. We’ve also been investing in at least $1,000 in about 30 ASX shares which includes the 10 we rate as Best Buys.
ASX Small Caps are on Sale!
The first point to make is that small caps are on sale. That’s for sure. Ansarada (AND) proves the point, as does the other stocks I mentioned this week that have spiked:
· Damstra (ASX:DTC)
· Pacific Current (ASX:PAC)
· City Chic (ASX:CCX)
· A2B (ASX:A2B)
· Southern Cross Electrical (ASX:SXE)
· Probiotec (ASX:PBP)
· Volpara Health (VHT)
You get the idea.
Reporting season: It’s all about Blue Chips
But at this point in the reporting season, it’s all about the big caps, because the small caps don’t tend to report until right at the end.
3 ASX Shares to invest in in 2024:
I want to talk about three stocks that you need to consider for your core ASX Share portfolio. What we are doing here is building up your base so that you can add high-growth small caps. Yes, it’s about timing, but it’s also about being able to afford to take risks. That’s what building a base of blue chips is about.
· CBA and CSL are two stocks that have great businesses and are gorillas in their respective areas. CSL still represents value at these prices, but CBA is a good stock to be buying if you’re building a portfolio.
Ever since it floated in the early 90s, analysts have been saying CBA is overvalued. What it does have is scale, which is why it might look expensive compared to competitors. It’s like Rio Tinto, because it’s so big, unit costs are much lower. Plus, it’s been run better over the years – it’s got superior systems and it’s got a bigger retail mortgage book.
CSL has a new guy at the helm. What hasn’t changed is its fantastic blood products business and what some might call optionality with its big pipeline of yet to be approved drugs.
· Then there is Wesfarmers (WES) – I like this company because it thinks long term and has cash coming through the door. This week’s result highlighted that Kmart is turning around let by its Anko homebrand.
We go to Kmart a lot and what we see is a big product range and value prices. What more could you want when times are tight? WES also has a lithium business, which gives it long-term potential and then there’s the retail juggernaut that is Bunnings.
#FinanceFriday
There you go, three core holdings that boost your ability (and my ability) to #GetRichWithRich. Make some trades today, which Caroline and I call #FinanceFriday. I do my finance admin, the portfolio checklist, do some trades, talk to you and have a beer.
